Paid Clinical Trials in El Paso, TX
As of September 2026, 189 paid clinical trials are recruiting in El Paso, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
El Paso offers studies at sites including El Paso Children's Hospital for conditions such as Obesity, Asthma, Overweight, Alzheimer Disease. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in El Paso
Trials by drug in El Paso
Filter results
Newly added in El Paso
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
169 clinical trials
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Pelacarsen Roll-over Extension Program
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Top Research Study Locations in El Paso
Researchers run research studies in El Paso, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| El Paso Children's Hospital | B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm, Acute Myeloid Leukemia | 21 |
| ANESC Research | Focal Epilepsy, Acute Treatment of Migraine, Agitation | 10 |
| Texas Oncology - West Texas | Breast Neoplasms, Advanced Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung | 5 |
| Renovatio Clinical - El Paso | Non-Small Cell Lung Cancer, Cancer, Carcinoma, Non-Small-Cell Lung | 5 |
| GSK Investigational Site | HIV Infections, Influenza, Human, Pulmonary Disease, Chronic Obstructive | 4 |
| Texas Arthritis Center | Juvenile Psoriatic Arthritis, Lupus Erythematosus, Systemic, Lupus Nephritis | 4 |
| Western Sky Medical Research | Asthma, Chronic Spontaneous Urticaria, Chronic Spontaneous Urticaria (CSU) | 4 |
| University of Texas at El Paso | Insulin Resistance, Activity Trackers, Obesity | 3 |
| David Turbay, MD | Obesity, Atherosclerotic Cardiovascular Disease, Heart Failure | 3 |
| Haracec Clinical Research | Post Traumatic Stress Disorder, Schizophrenia | 3 |
| Proactive El Paso,LLC | Alagille Syndrome, Moderately to Severely Active Crohns Disease, Pneumococcal Disease | 3 |
| University Medical Center of El Paso | Alcohol Use Disorder, Diabetes, Fracture Fixation, Internal | 3 |
| El Paso Eye Surgeons | Open-Angle Glaucoma, Primary Open Angle Glaucoma | 3 |
| Clinical Trial Site | Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma | 2 |
| 3A Research | Chronic Idiopathic Constipation (CIC), Severe Alopecia Areata | 2 |
| 3A Research Llc West Location | Hidradenitis Suppurativa (HS), NonSegmental Vitiligo | 2 |
| Academy Of Diabetes, Thyroid And Endocrine, PA | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 2 |
| Advanced Neurology Epilepsy and Sleep Center ANESC | Obesity, Obstructive Sleep Apnoea, Overweight | 2 |
| Ascendis Investigational Site | Growth Hormone Deficiency | 2 |
| Biorhythms Center for Integrative Sleep Medicine | Obesity, Obstructive Sleep Apnoea, Overweight | 2 |
| Department of Physical Therapy and Movement Science, University of Texas at El Paso | Healthy Adult | 2 |
| El Paso Medical Research Institute (Medresearch Inc) | Cancer-Associated Thrombosis (CAT), Venous Thromboembolism (VTE) | 2 |
| El Paso Texas Oncology | Early Breast Cancer, Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors | 2 |
| Rio Grande Urology | Oligometastatic Prostate Cancer (OMPC), PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy | 2 |
| Southwest Plastic Surgery | Breast Implant, Capsular Contracture Associated With Breast Implant, Capsular Contracture Grade III | 2 |
Active & Upcoming Studies in El Paso (2026)
Recruiting trials in El Paso grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (29 active studies)
- REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis · Phase 3 · Regeneron Pharmaceuticals
- Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer · Phase 3 · Pfizer
Neurology & pain (22 active studies)
- A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea · Phase 3 · Novo Nordisk A/S
Diabetes & metabolic (13 active studies)
- A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity · Phase 3 · Eli Lilly and Company
- A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight · Phase 3 · AstraZeneca
Cardiovascular (11 active studies)
Eye & vision (4 active studies)
Mental health & behavior (3 active studies)
HIV / STI (2 active studies)
- A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed · Phase 3 · ViiV Healthcare
- A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1 · Phase 2 · Gilead Sciences
Vaccines (1 active study)
- A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age · Phase 3 · GlaxoSmithKline
Pediatric (1 active study)
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Common conditions studied in El Paso
- Obesity (7 active studies)
- Asthma (6 active studies)
- Overweight (6 active studies)
- Alzheimer Disease (4 active studies)
- B Acute Lymphoblastic Leukemia (3 active studies)
- Graves' Disease (3 active studies)
Leading research sponsors in El Paso
- AstraZeneca
- Children's Oncology Group
- University of Texas, El Paso
- Novartis Pharmaceuticals
- National Cancer Institute (NCI)
Frequently asked questions
How many paid clinical trials are currently recruiting in El Paso?
There are approximately 189 recruiting clinical trials in El Paso, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in El Paso pay participants?
Most recruiting trials in El Paso compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in El Paso?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in El Paso?
The most common conditions under active study in El Paso include Obesity (7), Asthma (6), Overweight (6), Alzheimer Disease (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in El Paso?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in El Paso on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in El Paso?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in El Paso?
Recruiting research sites in El Paso include El Paso Children's Hospital, ANESC Research, Texas Oncology - West Texas, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in El Paso right now?
The largest active categories in El Paso are Cancer & tumors (29), Neurology & pain (22), Diabetes & metabolic (13). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.